Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Beauty Kadan, First Half Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 16%
3041 Beauty Kadan Holdings Co., Ltd. 【J-GAAP】
Earnings ReportBeauty Kadan Holdings Co., Ltd. <3041> [TSE Std] announced its financial results after the market closed on February 14th (15:30). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending June 2025 (July to December) turned into a loss of 33 million yen (compared to a profit of 17 million yen in the same period last year).
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to June period (2H) is expected to expand 74.4% from the same period last year, reaching 143 million yen.
In the most recent three-month period, from October to December (2Q), the consolidated ordinary profit decreased to 38 million yen, a 15.6% decrease compared to the same period last year. The operating profit margin worsened from 2.3% in the same period last year to 1.7%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2022 | 3,217 | 12 | 29 | 17 | 4.4 | 21.5 | Feb 14, 2023 | J-GAAP |
Jul - Dec, 2023 | 3,556 | 11 | 17 | 3 | 0.9 | 17.2 | Feb 14, 2024 | J-GAAP |
Jul - Dec, 2024 | 3,880 | -39 | -33 | -32 | -8.1 | ー | Feb 14, 2025 | J-GAAP |
YoY | +9.1% | - | - | - | - |
First Half Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2024 Guidance | ー | ー | ー | ー | - | 0 | Aug 14, 2024 | J-GAAP |
Jul - Dec, 2024 Results | 3,880 | -39 | -33 | -32 | -8.1 | 0 | Feb 14, 2025 | J-GAAP |
Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 3,426 | 73 | 82 | 25 | 6.3 | 4 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | 3,720 | 149 | 143 | 102 | 24.9 | 9 | Feb 14, 2025 | J-GAAP |
YoY | +8.6% | +104.1% | +74.4% | +308.0% | +295.9% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jun, 2023 | 6,413 | 124 | 135 | 88 | 21.9 | 9 | Aug 14, 2023 | J-GAAP |
Jun, 2024 | 6,982 | 84 | 99 | 28 | 7.0 | 4 | Aug 14, 2024 | J-GAAP |
Jun, 2025 Guidance | 7,600 | 110 | 110 | 70 | 17.1 | 9 | Aug 14, 2024 | J-GAAP |
YoY | +8.9% | +31.0% | +11.1% | +150.0% | +142.8% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 1,849 | 42 | 45 | 34 | 10.1 | 2.3 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 1,860 | 79 | 84 | 44 | 11.0 | 4.2 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 1,566 | -6 | -2 | -19 | -4.8 | -0.4 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 1,807 | -74 | -71 | -58 | -14.5 | -4.1 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 2,073 | 35 | 38 | 26 | 6.6 | 1.7 | Feb 14, 2025 | J-GAAP |
YoY | +12.1% | -16.7% | -15.6% | -23.5% | -34.9% |
Related Articles
Cacco, The Current Fiscal Year's Net Income to Narrow
Nxera Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
MACROMILL, First Half Net Income Increases by 62%, Oct-Dec Net Income Increases by 28%
jig.jp, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 8%
APPLE INTERNATIONAL, 22% Decrease in Ordinary Profit for The Current Fiscal Year
PIGEON, 3% Decrease in Ordinary Profit for The Current Fiscal Year
WASHINGTON HOTEL, The Current Fiscal Year Ordinary Profit Revised Upward by 37%, Dividend Revised Upward by 5 yen
kubell, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.
Will Smart, Net Income for The Current Fiscal Year, with a Change in the Fiscal Year End, is 40 million yen
Living Platform, Apr-Dec (Cumulative 3Q) Operating Profit Turns to Profit, Oct-Dec Operating Profit Turns to Profit